The Advisory Board (AB) meeting was held on the 28 of June 2021 in its annual meeting with representatives of national TB control programmes, WHO, the TESA-2 and EACCR-2 networks, TB-affected communities and technical assistance agencies, as well as scientific experts (see Consortium as a whole).

The goal of the AB is to advise the SC and EB at the strategic level on direction and the performance of PreFIT, its output, embedment in TB control, and strategies towards ensuring uptake of the validated assays.